patented technology to grow and expand adult Stem Cells
Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place
  • Demo Video
  • Private Messages
  • Edit My Profile
  • View/Edit Portfolio

AGORACOM News Flash

AGORACOM WIRE - WEDNESDAY MAY 30TH, 2012

GOLDEN HOPE MINES (TSXV:GNH) Confirms High Grade Intersection of 64.1 g/t Au (Gold) over 1m Read More 

  • The screen metallic analysis returned 82 g/t Au for an average grade of 93.5 g/t Au.
  • Two additional fire assays on the original pulp done prior to the screen metallic analyses returned 0.22 g/t Au and 0.12 g/t Au for an average fire assay grade of 0.41 g/t Au. The weighted average of all the fire assays and screen metallic assays from this 1-metre section in hole BD2011-184 is 64.1 g/t Au.

Sonomax® eers™ Custom Earbuds Announces Sponsorship of MUTEK 2012

CONTINENTAL ENERGY  Geothermal Energy Project Receives US$ 11.5 Million Grant Read More * Client

AGORACOM Launches Graphite Stocks Blog

Top Stories

  • FOCUS METALS (TSXV:FMS) Changes Its Name to Focus Graphite Inc. Read More   |   *SPONSOR

  • LOMIKO METALS (TSXV:LMK) Paul Gill Discusses Exploration Initiative with James West of Midas Letter Read More   |   *SPONSOR
  • GRAPHITE DEMAND Seen Surging from Fuel Cells, Nuclear Reactors, Graphene Read More

 

 

Message: NEWS!! 3 mnth patient follow-up data re patient receiving PLX-PAD!!!

Generic_profile
Rank: [?]
Treasurer
Points: [?]
13873
Rating: [?]
Votes: 71 Score: 2.4
  • Currently 2.5/5 Stars.
Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.

EDIGOKIE..at least we win 2 ways with this one..I have a special interest in

posted on Nov 19, 09 08:10AM

the PAD trials as one day I'm sure this will be my problem. it's amazing to think of all the joy that could result in the success of placental stem cell implantation

New Message

Please login to post a reply

AGORACOM Quick Tips

Small-Cap CEO Lessons - Is Your CEO Out Of Touch? ... Not Anymore
Watch
Today's Show
in 00:00:000

President's D.D.

4-17-12, Pluristem Receives U.S. FDA Clearance for Phase II Clinical Trial for the treatment of peripheral artery disease (PAD). read more

Stock Quote

Hub Leaders